Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
161M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
28.7M
-
Shares change
-
+10.4M
-
Total reported value, excl. options
-
$320M
-
Value change
-
+$115M
-
Number of buys
-
47
-
Number of sells
-
-16
-
Price
-
$11.14
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q2 2019
70 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q2 2019.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.7M shares
of 161M outstanding shares and own 17.9% of the company stock.
Largest 10 shareholders include FMR LLC (5.36M shares), Redmile Group, LLC (3.22M shares), Svennilson Peter (3.1M shares), Versant Venture Management, LLC (3.1M shares), Blackstone Group Inc (2.57M shares), FRAZIER MANAGEMENT LLC (2.06M shares), Casdin Capital, LLC (1.77M shares), BlackRock Inc. (1.53M shares), VANGUARD GROUP INC (971K shares), and Alphabet Inc. (929K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.